ProCE Banner Activity

New and Emerging IBD Treatments: Our Take on Data From Crohn’s & Colitis Congress 2019

Clinical Thought
We highlight our thoughts on the most recent data for 3 new and emerging IBD treatments.

Released: June 26, 2019

Expiration: June 24, 2020

No longer available for credit.

Share

Faculty

Baldeep S. Pabla

Baldeep S. Pabla, MD, MSCI

Gastroenterology Fellow
Department of Internal Medicine; Division of Gastroenterology, Hepatology, and Nutrition
Vanderbilt University Medical Center
Nashville, Tennessee

David A. Schwartz

David A. Schwartz, MD, FACG, AGAF

Professor of Medicine
Department of Gastroenterology
Director, IBD Center
Vanderbilt University
Nashville, Tennessee

Supporters

Supported by educational grants from

Celgene without Corporation

Takeda Pharm USA

Partners

AGA CCF

ProCE Banner

Faculty Disclosure

Primary Author

Baldeep S. Pabla, MD, MSCI

Gastroenterology Fellow
Department of Internal Medicine; Division of Gastroenterology, Hepatology, and Nutrition
Vanderbilt University Medical Center
Nashville, Tennessee

Baldeep S. Pabla, MD has no real or apparant financial relationships to disclose.

David A. Schwartz, MD, FACG, AGAF

Professor of Medicine
Department of Gastroenterology
Director, IBD Center
Vanderbilt University
Nashville, Tennessee